The U.S. Dow fell more than 1% intraday! iQiyi up more than 32% Baidu up more than 8%

With the intensification of the conflict between Russia and Ukraine, the sanctions imposed by Europe and the United States on Russia have increased, and a new round of volatility has emerged in the global market.

As of press time, the U.S. Stock Dow fell 342.91 points at 33,549.69 points, or 1.01 percent; the Nasdaq fell 73.21 points at 13,678.19 points, or 0.53 percent; and the S&P 500 fell 30.03 points at 4,343.91 points, or 0.69 percent.

In terms of technology stocks, Apple rose 0.05%; Facebook fell 1.09%; Amazon fell 0.5%; Microsoft fell 0.31%; Google rose 0.23%; Netflix fell 1.13%; Tesla fell 1.23%.

In terms of Chinese stocks, Alibaba rose 4.07%; Baidu rose 8.45%; iQiyi rose 32.09%; JD.com rose 3.49%; NetEase rose 0.09%; Sina Weibo rose 1.02%; Pinduoduo rose 2.04%; Qutoutiao rose 1.7%; Weilai fell 2.89%; Xunlei rose 0.58%; Momo rose 2.78%; Huanju Times rose 2.25%; Huya rose 3.24%; Bilibili rose 2.88%; and Autohome rose 1.73%.

European markets remained safe-haven on Tuesday, with several major stock indexes falling more than 2 percent.

In commodity markets, oil prices rose sharply: WTI crude oil rose as much as 3.5% during the day; WTI crude oil once exceeded $100 / barrel, the first time since 2014.

In the bond market, the 10-year Treasury yield fell 7 basis points to 1.770%, the lowest level since January, and the 2-year Treasury yield fell 6 basis points to 1.365%.

Morgan Stanley: The Russian-Ukrainian conflict continues to suppress risk appetite The US stock market is under pressure in the short term

Despite the intention of easing the conflict between Russia and Ukraine, the two sides held talks on Monday and agreed to hold the next talks. But Morgan Stanley warned that doesn't mean the stock market is completely out of risk. Lisa Shalett, chief investment officer at Morgan Stanley Wealth Management, said that no matter how the situation in Russia and Ukraine develops, it is difficult for the stock market to return to normal as quickly as it has in the past after the initial blow, "This (Russo-Ukrainian war) is very serious, I think in the coming weeks will suppress investors' risk appetite, we continue to be cautious about the market." ”

Company news

The legendary biological CAR-T cell immunotherapy was approved for marketing by the FDA

After the market hours on Monday, the U.S. listing application of China Stock Legend BioSynthia was approved by the FDA for the treatment of adult relapsed/refractory multiple myeloma (MM), becoming the first FDA-approved cell therapy product in China and the second CAR-T cell immunotherapy approved to target BCMA in the world.

Chinese stock earnings: Baidu's non-advertising business revenue soared iQiyi's losses narrowed

On the evening of March 1, Beijing time, The Chinese stock Baidu disclosed its 2021 Q4 financial report, with revenue of 33.09 billion yuan and net profit attributable to the parent company of 4.1 billion yuan during the reporting period, both exceeding market expectations. The company achieved a total revenue of 124.5 billion yuan in 2021, of which non-advertising revenue such as AI and intelligent cloud reached 21.2 billion yuan, an increase of 71% year-on-year.

iQIYI disclosed its financial report that the company's annual revenue reached 30.6 billion yuan, of which the non-GAAP operating loss in the fourth quarter was 520 million yuan and the annual operating loss was 3 billion yuan, both narrowed year-on-year. As of the end of the fourth quarter, the total number of daily subscription members of the platform was 97 million, compared with 104 million in the previous quarter.

Toyota motor will resume production at its local plant on Wednesday

Japan's Toyota Motor Corporation on Tuesday suspended operations at all 14 of its homegrown plants, affected by cyberattacks on major suppliers. The company confirmed to the media on Tuesday that the affected plants will resume operations from March 2. A Toyota spokesperson said it could take another week or two to completely resolve the issue, and it is currently using workarounds to resume operations first.

Lucid lowered production guidance

After hours on Monday, high-end electric vehicle maker Lucid announced that it would cut its production guidance for this year from 20,000 to 12,000 units due to severe supply chain and logistics challenges. In fact, the company delivered a total of 125 new cars last year, which is also below the target of 577. According to the earnings report, the company's loss widened to $1.05 billion in the fourth quarter of last year. Also on Monday, Lucid also announced that it would build a new production facility in Saudi Arabia, scheduled to start construction in the first half of this year, with a design peak of 150,000 units a year.

Oil prices are climbing Chevron announced an increase in its share repurchase target

On Tuesday, local time, US energy giant Chevron announced that it would raise its annual stock repurchase target from $3-5 billion to $50-100. While well-to-do, the company continues to maintain its guidance of $15-17 billion in upstream capex for the year 2026, while expecting production costs per barrel of crude to fall 10 percent from last year's levels.

The Pfizer bacterial infection vaccine experiment failed to meet its main objectives

Pfizer said tuesday that the results of its Clostridium difficile vaccine experiment did not meet the main target, of which the effective rate after three injections was 31%, while the effective rate of two injections was 28.6%. However, the Company confirmed that it will further assess its ability to alleviate the symptoms of infection.

Zoom Video's earnings guidance was weaker than expected

After hours on Monday, Zoom Video announced its results for the fourth quarter of last year, with revenue of $1.07 billion and EPS of $1.29 both beating market expectations. However, the company expects 2022 revenue to be between $4.53 billion and $4.55 billion, and EPS guidance of $3.45-3.51 is below market expectations.

The report card of the new car-making forces in February was released

Ideal Cars delivered 8,414 Ideal ONE units in February, up 265.8% from February 2021. Since its delivery, the ideal ONE has delivered 144,770 vehicles.

Xiaopeng Automobile delivered a total of 6,225 units in February, an increase of 180% year-on-year. In terms of single-model deliveries, the Xiaopeng P7 delivered 3,537 units, an increase of 151% year-on-year; the Xiaopeng P5 delivered 2,059 units; and the Xiaopeng G3 series delivered 629 units.

NIO delivered a total of 6,131 smart electric vehicles in February, an increase of 9.9% year-on-year. As of the end of February 2022, NIO has delivered a total of 182,853 smart electric vehicles.